UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Effects of MGCD265, an oral Tyrosine Kinase Inhibitor, in Combination with Erlotinib or Docetaxel for Treatment of Advanced Gastroesophageal and Nsclc Tumors

Annals of oncology, 2012-09, Vol.23, p.ix169

2012

Volltextzugriff (PDF)

492P - Clinical Effects of MGCD265, an oral Tyrosine Kinase Inhibitor, in Combination with Erlotinib or Docetaxel for Treatment of Advanced Gastroesophageal and Nsclc Tumors

Annals of oncology, 2012-09, Vol.23, p.ix169-ix169

2012

Volltextzugriff (PDF)

The Impact of Wearable Technologies on Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-Analysis

Curēus (Palo Alto, CA), 2024-10

2024

Volltextzugriff (PDF)

MGCD265, an oral Met/VEGFR multitargeted receptor tyrosine kinase inhibitor, in combination with erlotinib: Phase I clinical experience

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3083-3083

2011

Volltextzugriff (PDF)

Determination of the maximum tolerated dose (MTD) of MGCD265, an oral Met/VEGFR multitargeted receptor tyrosine kinase inhibitor, in combination with docetaxel

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3032-3032

2011

Volltextzugriff (PDF)

HPLC determination of indalpine and its major metabolite in human plasma and a pharmacokinetic application

Biopharmaceutics & drug disposition, 1987-11, Vol.8 (6), p.507-517

1987

Volltextzugriff (PDF)

Some bending properties of films

Journal of applied polymer science, 1978-05, Vol.22 (5), p.1443-1449

1978

Volltextzugriff (PDF)

Some Bending Measurements on Yarns

The Journal of The Textile Institute, 1977-05, Vol.68 (5), p.188-189

1977

Volltextzugriff (PDF)

Bending properties of yarns and films

El- Tawashi, M K

1978

Volltextzugriff (PDF)

Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure

Biopharmaceutics & drug disposition, 1991-03, Vol.12 (2), p.95-104

1991

Volltextzugriff (PDF)

Pharmacokinetics of intravenous diltiazem and five of its metabolites in patients with chronic renal failure and in healthy volunteers

Biopharmaceutics & drug disposition, 1991-03, Vol.12 (2), p.105-112

1991

Volltextzugriff (PDF)

Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients

Virus research, 2021-01, Vol.292, p.198226-198226, Article 198226

2021

Volltextzugriff (PDF)

Inflammatory and Adipokine Status from Early to Midpregnancy in Arab Women and Its Associations with Gestational Diabetes Mellitus

Disease markers, 2021, Vol.2021, p.8862494-8

2021

Volltextzugriff (PDF)

Successful Manufacturing of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy from Cryopreserved Melanoma Tumors Shipped from Australia

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S226-S227

2022

Volltextzugriff (PDF)

287 - Successful Manufacturing of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy from Cryopreserved Melanoma Tumors Shipped from Australia

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S226-S227

2022

Volltextzugriff (PDF)

Acalabrutinib, a second-generation bruton tyrosine kinase (Btk) inhibitor, in previously untreated chronic lymphocytic leukemia (CLL)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.7521-7521

2016

Volltextzugriff (PDF)

MGCD265, a multitargeted oral tyrosine kinase receptor inhibitor of Met and VEGFR, in combination with erlotinib in patients with advanced solid tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13602-e13602

2012

Volltextzugriff (PDF)

MGCD265, a multitargeted oral tyrosine kinase receptor inhibitor of Met and VEGFR, in combination with docetaxel

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13604-e13604

2012

Volltextzugriff (PDF)

Morphic features of solid particles after micronization in the fluid energy mill

International journal of pharmaceutics, 1987-02, Vol.35 (1), p.81-89

1987

Volltextzugriff (PDF)

Application of fractal dimension to the study of the surface ruggedness of granular solids and excipients

Journal of pharmaceutical sciences, 1988-08, Vol.77 (8), p.724-726

1988

Volltextzugriff (PDF)

Morphic features variation of solid particles after size reduction: sonification compared to jet mill grinding

International journal of pharmaceutics, 1988-11, Vol.47 (1), p.171-177

1988

Volltextzugriff (PDF)

Effect of Surface Geometry and Morphic Features on the Flow Characteristics of Microsphere Suspensions

Journal of pharmaceutical sciences, 1990-10, Vol.79 (10), p.929-933

1990

Volltextzugriff (PDF)

Reduced kallikrein excretion by liposome-encapsulated cyclosporin in the rat

Journal of pharmacy and pharmacology, 1993-02, Vol.45 (2), p.146-148

1993

Volltextzugriff (PDF)

Calcium oxalate crystal growth in the presence of mucin

Scanning microscopy, 1991-12, Vol.5 (4), p.1019

1991

Volltextzugriff (PDF)

Liposomal delivery system for the targeting and controlled release of praziquantel

Drug development and industrial pharmacy, 1992, Vol.18 (3), p.303-317

1992

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(46)
Dissertationen
(1)

Sprache

Englisch
(43)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(17)
Humans
(13)
Biological And Medical Sciences
(12)
Crystallization
(12)
Medical Sciences
(11)
Pharmacology. Drug Treatments
(11)
Pharmacology & Pharmacy
(10)
Microscopy, Electron, Scanning
(7)
Technology
(7)
General Pharmacology
(6)
Male
(6)
Microscopy
(6)
Particle Size
(6)
Calcium Oxalate - Urine
(5)
Chemistry, Medicinal
(5)
Female
(5)
Pharmaceutical Technology. Pharmaceutical Industry
(5)
Surface Properties
(5)
Urology & Nephrology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical Effects of MGCD265, an oral Tyrosine Kinase Inhibitor, in Combination with Erlotinib or Docetaxel for Treatment of Advanced Gastroesophageal and Nsclc Tumors

492P - Clinical Effects of MGCD265, an oral Tyrosine Kinase Inhibitor, in Combination with Erlotinib or Docetaxel for Treatment of Advanced Gastroesophageal and Nsclc Tumors

The Impact of Wearable Technologies on Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-Analysis

MGCD265, an oral Met/VEGFR multitargeted receptor tyrosine kinase inhibitor, in combination with erlotinib: Phase I clinical experience

Determination of the maximum tolerated dose (MTD) of MGCD265, an oral Met/VEGFR multitargeted receptor tyrosine kinase inhibitor, in combination with docetaxel

HPLC determination of indalpine and its major metabolite in human plasma and a pharmacokinetic application

Some bending properties of films

Some Bending Measurements on Yarns

Bending properties of yarns and films

Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure

Pharmacokinetics of intravenous diltiazem and five of its metabolites in patients with chronic renal failure and in healthy volunteers

Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients

Inflammatory and Adipokine Status from Early to Midpregnancy in Arab Women and Its Associations with Gestational Diabetes Mellitus

Successful Manufacturing of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy from Cryopreserved Melanoma Tumors Shipped from Australia

287 - Successful Manufacturing of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy from Cryopreserved Melanoma Tumors Shipped from Australia

Acalabrutinib, a second-generation bruton tyrosine kinase (Btk) inhibitor, in previously untreated chronic lymphocytic leukemia (CLL)

MGCD265, a multitargeted oral tyrosine kinase receptor inhibitor of Met and VEGFR, in combination with erlotinib in patients with advanced solid tumors

MGCD265, a multitargeted oral tyrosine kinase receptor inhibitor of Met and VEGFR, in combination with docetaxel

Morphic features of solid particles after micronization in the fluid energy mill

Application of fractal dimension to the study of the surface ruggedness of granular solids and excipients

Morphic features variation of solid particles after size reduction: sonification compared to jet mill grinding

Effect of Surface Geometry and Morphic Features on the Flow Characteristics of Microsphere Suspensions

Reduced kallikrein excretion by liposome-encapsulated cyclosporin in the rat

Calcium oxalate crystal growth in the presence of mucin

Liposomal delivery system for the targeting and controlled release of praziquantel

Suchergebnisse filtern